Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.51534 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.48554 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.47934 | 20 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.41865 | 20 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.42137 | 20 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.54253 | 20 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.54771 | 22 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.45476 | 20 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.43218 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.47283 | 20 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.47091 | 20 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.4574 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.47848 | 20 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.47339 | 20 |